COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.
- DOI
- 10.1111/fcp.12695
- Published
- 2022 Feb
- Container
- Fundamental & clinical pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/fcp.12695,
title = {COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.},
author = {Dernoncourt A and Schmidt J and Duhaut P and Liabeuf S and Gras-Champel V and Masmoudi K and Bennis Y and Batteux B},
year = {2022},
journal = {Fundamental \& clinical pharmacology},
doi = {10.1111/fcp.12695},
url = {https://doi.org/10.1111/fcp.12695}
}RIS
TY - JOUR TI - COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database. AU - Dernoncourt A AU - Schmidt J AU - Duhaut P AU - Liabeuf S AU - Gras-Champel V AU - Masmoudi K AU - Bennis Y AU - Batteux B PY - 2022 JO - Fundamental & clinical pharmacology DO - 10.1111/fcp.12695 UR - https://doi.org/10.1111/fcp.12695 ER -
APA
A, D., J, S., P, D., S, L., V, G., K, M., Y, B., & B, B. (2022). COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.. Fundamental & clinical pharmacology. https://doi.org/10.1111/fcp.12695
Source records
- pubmed · retrieved 2026-09-26T21:00:25.590Z